background
banner

CEPROTIN 500 IU Price

Active Substance: Human Protein C.

4707
UAD , based on 7541 reviews.
View Drug details

Overview

Welcome to Dwaey, specifically on CEPROTIN 500 IU page.
This medicine contains an important and useful components, as it consists of
Human Protein Cis available in the market in concentration

Name

Levocarnitine Syrup

Precaution

Levocarnitine syrup, a form of L-carnitine, is a naturally occurring compound that plays a critical role in the transport of fatty acids into mitochondria for energy production. It is used as a supplement to treat or prevent carnitine deficiency, which can be caused by conditions such as end-stage renal disease, genetic disorders, or certain metabolic conditions. When prescribing levocarnitine syrup, several precautions should be considered. Patients with hypersensitivity to levocarnitine or its components should not use the syrup. Caution is advised when administering levocarnitine in patients with a history of seizures, as there is limited evidence on its use in such populations. Levocarnitine should also be used with care in pregnant or breastfeeding women. While levocarnitine is classified as a category C drug (with limited evidence on safety), it should only be used during pregnancy if the potential benefits outweigh the risks to the fetus. There are no substantial data to confirm whether levocarnitine passes into breast milk, so caution should be exercised when administering to breastfeeding mothers. Regular monitoring of renal function is crucial for patients with kidney problems, particularly those with end-stage renal disease, since carnitine supplementation may accumulate in the body in these cases. Close monitoring for potential adverse effects like gastrointestinal disturbances or muscle weakness should be performed, especially in long-term use.

Indication

Levocarnitine syrup is primarily indicated for the treatment and prevention of carnitine deficiency, which can occur due to various underlying medical conditions, including end-stage renal disease, genetic disorders (such as primary and secondary systemic carnitine deficiency), and certain metabolic disorders. Carnitine is necessary for the transportation of long-chain fatty acids into mitochondria for energy production, so a deficiency can result in muscle weakness, fatigue, and other metabolic abnormalities. Levocarnitine is often used in patients on hemodialysis, as renal failure impairs the kidney’s ability to synthesize or conserve carnitine, leading to a deficiency. In these patients, levocarnitine supplementation helps to replenish carnitine levels, improving energy production and preventing associated muscle weakness or cardiovascular issues. Off-label uses of levocarnitine may include treating patients with conditions such as obesity or diabetes, as it has been suggested to support fat metabolism and improve metabolic efficiency. However, more evidence is needed to fully establish these off-label uses.

Contra indication

Levocarnitine syrup is contraindicated in patients with hypersensitivity to levocarnitine or any of the syrup’s ingredients. Allergic reactions, although rare, can include symptoms like rash, itching, and swelling, particularly in sensitive individuals. It should also be avoided in patients with untreated hypercarnitinemia (excessive carnitine levels in the blood), as this can lead to an increased risk of toxicity. For individuals with pre-existing kidney disorders, such as nephrotic syndrome or kidney failure, levocarnitine should be prescribed with caution and under medical supervision, as excessive supplementation in these patients could lead to an accumulation of carnitine. Levocarnitine syrup is not typically recommended for use in children under 12 years old unless prescribed by a healthcare provider. In pediatric patients, dosing should be carefully calculated based on weight and specific needs, and they should be monitored closely for side effects, particularly gastrointestinal issues or the potential for overdose.

Side Effect

Levocarnitine syrup is generally well-tolerated, but side effects can occur, particularly when used in high doses or for prolonged periods. Some of the more common side effects include: - **Gastrointestinal Issues**: The most common side effects are gastrointestinal disturbances, such as nausea, vomiting, abdominal cramps, and diarrhea. These effects are typically dose-dependent and can be minimized by adjusting the dosage or taking the medication with food. - **Body Odor**: Some patients may experience a fishy body odor, which is thought to be related to the metabolism of carnitine in the body. This is a well-known side effect of carnitine supplementation, particularly in high doses. Reducing the dosage or splitting doses throughout the day may help alleviate this issue. - **Muscle Weakness**: Although rare, long-term use of levocarnitine in excessive doses can sometimes lead to muscle weakness. Patients should report any unusual muscle symptoms to their healthcare provider. - **Allergic Reactions**: Although rare, some individuals may experience allergic reactions, including rash, itching, and more severe reactions such as swelling of the face, lips, or tongue, which may indicate an anaphylactic response. Immediate medical attention should be sought in these cases. Serious adverse effects are uncommon, but patients should seek medical attention if they experience signs of overdose, such as extreme weakness, dizziness, or confusion.

Pregnancy Category ID

2

Mode of Action

Levocarnitine, the active ingredient in levocarnitine syrup, is a naturally occurring substance that plays a vital role in the transportation of long-chain fatty acids into mitochondria, where they are metabolized to produce energy. In conditions where carnitine levels are low due to metabolic disorders or renal failure, the body cannot effectively utilize fatty acids for energy production, leading to fatigue, muscle weakness, and other metabolic disturbances. By supplementing with levocarnitine, the body’s ability to use fat as an energy source is restored, enhancing mitochondrial function and improving overall energy production. This is particularly beneficial for patients with conditions that impair carnitine synthesis or absorption, such as kidney disease, metabolic disorders, or malnutrition. Levocarnitine also plays a role in the removal of toxic compounds from cells, particularly in tissues such as muscle and the heart, which require high amounts of energy to function. Therefore, by restoring carnitine levels, levocarnitine helps improve cellular energy metabolism and reduces symptoms associated with deficiencies.

Interaction

Levocarnitine syrup has limited interactions with other medications, but it can affect the metabolism or absorption of certain drugs. Some potential interactions include: - **Anticonvulsants**: Medications such as valproate can interfere with carnitine metabolism, leading to lower levels of carnitine in the body. If a patient is taking valproate or other anticonvulsants, levocarnitine supplementation may be necessary to prevent deficiency. - **Warfarin**: Although not a direct interaction, there have been some reports suggesting that carnitine supplementation may alter the anticoagulant effects of warfarin. Regular monitoring of INR (International Normalized Ratio) levels may be necessary when both medications are prescribed together. - **Thyroid Hormones**: Levocarnitine may influence the metabolism of thyroid hormones, although the clinical significance of this interaction is minimal. However, patients on thyroid medication should be monitored for any changes in their thyroid function when starting or discontinuing levocarnitine. - **Alcohol and Lifestyle**: Alcohol consumption does not directly interfere with levocarnitine metabolism, but excessive alcohol use can negatively impact liver and kidney function, potentially exacerbating the symptoms of carnitine deficiency. Patients should be advised to limit alcohol intake to avoid further strain on these organs. To minimize interaction risks, patients should inform their healthcare provider of all medications they are currently taking before starting levocarnitine therapy.

Pregnancy Category Note

Information not available

Adult Dose

The typical adult dose of levocarnitine syrup for the treatment of carnitine deficiency is 1 to 3 grams daily, divided into two or three doses. For most adults, the starting dose is usually around 1 gram per day, which can be adjusted based on individual needs, medical conditions, and response to therapy. For individuals undergoing hemodialysis, higher doses of up to 6 grams per day may be necessary to replace the carnitine lost during the dialysis process. The syrup should be taken orally, and the dose can be adjusted by the healthcare provider to ensure adequate supplementation of carnitine levels. Patients should follow the dosing instructions provided by their healthcare provider and avoid exceeding the recommended dose unless advised by their doctor.

Child Dose

Levocarnitine syrup is sometimes used in pediatric patients with carnitine deficiency, though the appropriate dose is typically based on the child's weight and age. The standard starting dose for children is generally around 50-100 mg/kg per day, divided into two or three doses. This dosage can be adjusted based on the clinical response and any potential side effects. In neonates or young children with severe carnitine deficiency, higher doses may be required, and it is essential to monitor the child closely for any adverse effects, particularly gastrointestinal disturbances or signs of overdose. Pediatric patients with renal insufficiency or other conditions should be monitored carefully to ensure proper dosing.

Renal Dose

In patients with renal impairment, especially those with end-stage renal disease undergoing dialysis, levocarnitine supplementation is often necessary. These patients are at risk of significant carnitine loss during hemodialysis. The typical dose for patients on dialysis may range from 1 to 3 grams per day, and higher doses may be required in some cases to compensate for the loss during dialysis. For individuals with mild to moderate renal impairment who are not on dialysis, the usual adult dosage of 1 to 3 grams per day is appropriate. Monitoring of renal function and carnitine levels is advised, as impaired renal clearance could lead to an accumulation of the drug in the body.

Administration

Information not available

banner

Report Error

Please feel welcome to contact us with any price or medical error. Our team will receive any reports.